Not Yet Recruiting
Safety and Efficacy Study of Safusidenib in Participants With Grade 2 IDH1-Mutant Glioma
NCT07712757
- Conditions
- Astrocytoma, Astrocytoma IDH Mutant Grade 2, Glioma, +11 more
- Locations
-
Not specified